Apyx Medical
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $13,884 | $12,490 | $19,164 | $12,877 |
Gross Profit | 8,870 | 4,672 | -2,012 | 8,297 |
EBITDA | -1,358 | -429 | 482 | -332 |
EBIT | -1,554 | -631 | 261 | -464 |
Net Income | -3,243 | -2,108 | -1,299 | -1,984 |
Net Change In Cash | 13,884 | 12,490 | 19,164 | 12,877 |
Free Cash Flow | -3,556 | -632 | -2,805 | -4,054 |
Cash | 27,617 | 31,137 | 31,740 | 25,135 |
Basic Shares | 42,163 | 42,163 | 42,163 | 40,729 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $52,844 | $48,102 | $52,349 | $44,510 |
Gross Profit | 19,033 | 29,360 | 33,759 | 29,131 |
EBITDA | -4,591 | -16,801 | -18,112 | -22,006 |
EBIT | -5,246 | -17,400 | -18,804 | -22,896 |
Net Income | -11,211 | -23,463 | -18,713 | -23,184 |
Net Change In Cash | 52,844 | 48,102 | 52,349 | 44,510 |
Cost of Revenue | -21,073 | |||
Free Cash Flow | -9,115 | -18,769 | -5,782 | -21,290 |
Cash | 31,740 | 31,741 | 43,652 | 10,192 |
Basic Shares | 42,163 | 35,542 | 34,622 | 34,516 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.07 |
2026-03-31 | -$0.05 |
2025-12-31 | -$0.03 |
2025-09-30 | -$0.05 |